An interventional study of Brisk walk and jog and Normal walk in Chronic Non-Specific Low Back Pain, sponsored by Dow University of Health Sciences. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 48 Years. Per ClinicalTrials.gov, last updated 2026-06-12.
Sponsored by Dow University of Health Sciences · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 223 studies in Low Back Pain with a site in Pakistan — 67 open to participants now, 79 under way, none of them phase 3. Low Back Pain · Pakistan.
Among the 223 studies in Low Back Pain with a site in Pakistan, this one is the 17th largest by planned enrollment of the 216 interventional ones that give a count, is one of 31 that started in 2026, is one of 216 with no phase, reaches primary completion later than 67 of the 78 other live ones, and was the 198th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →67 of the 223 studies in Low Back Pain with a site in Pakistan are open now. Recruiting first, the newest first:
University of Karachi · Sites in Pakistan
Ages 18–45
Riphah International University · Sites in Pakistan
Ages 18–30
Riphah International University · Sites in Pakistan
Ages 25–55
Riphah International University · Sites in Pakistan
Ages 35–50
Riphah International University · Sites in Pakistan
Ages 20–40
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 20 Years to 48 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
223 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 31 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 42 across the 216 interventional studies, 180 across the 7 observational. Of the 123 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 223 has an industry lead sponsor. The 10 most frequent:
Dow University of Health Sciences is the lead sponsor of 180 studies on the registry; 34 are open to participants now.
Dow University of Health Sciences has 7 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
12 of the studies in Low Back Pain with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07645859Dow University of Health SciencesComparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain Patients | 2026-12 |
| NCT06910982University of KarachiYoga and Mindfulness for Chronic Low Back Pain: A Randomized Controlled Trial | 2026-12-30 |
| NCT07912060University of Management and Technology LahoreIntegrated Feldenkrais Method With and Without DNS for Chronic Low Back Pain in Females | 2026-12-31 |
| NCT07912073University of Management and Technology LahoreComparative Effects of Kinetic Control Training and Neural Mobilization in Lumbar Radiculopathy | 2026-12-31 |
| NCT07892079University of Management and Technology LahoreEffects of Motor Control Exercises With and Without Pressure Biofeedback in Recurrent Low Back Pain (MCE) | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 223 studies in Low Back Pain with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to compare the HIIT with MICT in chronic non-specific low back pain patients. The main questions it aims to answer are:
Researcher will compare the HIIT to MICT to see the effects on CNSLBP
Participants will be:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A total of 40 participants will be enrolled in this group. Sessions will be conducted 3 times a week, each session lasting for 25 minutes. The duration breakdown is as follows: 3 minutes of warm-up, 6 bouts of HIIT (1 min of HIIT at 85-90% of HRmax, 2 min of recovery at 74-80% of HRmax), and 4 min of cool down. The intensity will be monitored using HR and the Borg Rating of Perceived Exertion. The mode of exercise will involve brisk walk and jog. At the end of each session, participants will perform 5-10 minutes stretching exercises targeting major muscle groups.
Other: Brisk walk and jog
A total of 40 participants will be enrolled in this group. Sessions will be conducted 5 times a week, each session lasting for 46 minutes. The duration breakdown is as follows: 3 minutes of warm-up, 40 min of HIIT (at 60-70% of HRmax), and 3 min of cool down. The intensity will be monitored using HR and Borg Rating of Perceived Exertion. The mode of exercise will involve normal walk. At the end of each session, participants will perform 5-10 minutes stretching exercises targeting major muscle groups.
Other: Normal walk
High-Intensity Interval Training
Moderate-Intensity Continuous Training
Numeric Pain Rating Score (NPRS)
Low back pain persisting for \> 12 weeks with no identifiable specific cause or underlying pathology Score: Mild to moderate (3-5)
Time frame: 6 weeks
Modified Oswestry Disability Index for disability
Disability percentage derived from 10-item ODI scores 20-40% considered mild to moderate and eligible.
Time frame: 6 weeks
Short Form-12 for Quality of Life
Time frame: 6 weeks
Modified Bruce Treadmill protocol for CV endurance
Time frame: 6 weeks
Bioelectrical Impedance Analysis (BIA) for body composition
Time frame: 6 weeks
height and weight for Body Mass Index
Time frame: 6 weeks
Waist Hip Ratio for fat distribution
Time frame: 6 weeks
Plan to share: No
Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 7 months is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dow University of Health Sciences →